APAC
South Korea’s Clonell Unveils “Ultimate Regenerative Medicine Platform,” Promising Patient-Specific Stem Cells to Tackle Immune Rejection
2026-01-07
AI-Designed B Cell–Reactive Neoantigens Open a New Chapter for Personalized Cancer Vaccines
2026-01-05
Enterovirus Hits 6-Year Peak: 12,000 Weekly Cases Expose a Critical Void in Neonatal Diagnostics
2025-12-11
Taiwan’s SNQ Joins Forces with ICHOM to Drive Patient-Centered Healthcare and Quality Enhancement
2025-12-11
Evergreen VC Fund Drives Cross-sector Synergy, Connecting Global and Taiwanese Biotech Ecosystems
2025-12-10
Adagene–Third Arc Bio Seal Up to $840M SAFEbody CD3 Deal to Advance Safer T-Cell Engagers
2025-11-20
From AI Tools to Rare Disease Breakthroughs, Hong Kong Shows How Fast Genomic Medicine Is Moving
2025-11-18
Japan’s Biotech Is Repositioning for Scale: JBA’s Tsukamoto on Capital, Capacity, and Cross-Border Models
2025-11-17
Indian Generics Gain Ground in China as the Global Procurement Landscape Demands a New Industrial Model
2025-11-13
LATEST
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
EVENT
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea



